Chi, K. N., Gedye, C., Belkoff, L., Barata, P. C., Bernard-Tessier, A., Graff, J. N., Matsubara, N., Sandhu, S., Schweizer, M. T., Stein, M. N., Amsberg, G. V., Siddiqui, B. A., Wei, X. X., Hosseini, M., Kramer, K., Moussa, F., Wang, S. C., Dibaj, S., Gaut, D. L., Castro, E. (2026). A phase 3 randomized, double-blind, placebo-controlled study of a pasritamig plus best supportive care in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5136